These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31032639)
1. 3,3'-Diindolylmethane Inhibits TNF-α- and TGF-β-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells. Lee J Nutr Cancer; 2019; 71(6):992-1006. PubMed ID: 31032639 [TBL] [Abstract][Full Text] [Related]
2. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells. Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351 [TBL] [Abstract][Full Text] [Related]
3. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Lee J; Hahm ER; Marcus AI; Singh SV Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer. Lee GA; Hwang KA; Choi KC Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962 [TBL] [Abstract][Full Text] [Related]
5. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway. Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980 [TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway. Kim BG; Kim JW; Kim SM; Go RE; Hwang KA; Choi KC Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316692 [TBL] [Abstract][Full Text] [Related]
7. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis. Lee GA; Hwang KA; Choi KC Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938 [TBL] [Abstract][Full Text] [Related]
8. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Sehrawat A; Singh SV Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039 [TBL] [Abstract][Full Text] [Related]
9. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation. Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953 [TBL] [Abstract][Full Text] [Related]
10. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
11. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways. Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913 [TBL] [Abstract][Full Text] [Related]
12. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells. Galarza TE; Táquez Delgado MA; Mohamad NA; Martín GA; Cricco GP Biochem Pharmacol; 2020 Oct; 180():114177. PubMed ID: 32721509 [TBL] [Abstract][Full Text] [Related]
13. The effect of TGF-beta-induced epithelial-mesenchymal transition on the expression of intracellular calcium-handling proteins in T47D and MCF-7 human breast cancer cells. Mahdi SH; Cheng H; Li J; Feng R Arch Biochem Biophys; 2015 Oct; 583():18-26. PubMed ID: 26247838 [TBL] [Abstract][Full Text] [Related]
14. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS; Choi KC; Hwang KA Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941 [TBL] [Abstract][Full Text] [Related]
15. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Sengupta S; Jana S; Bhattacharyya A Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534 [TBL] [Abstract][Full Text] [Related]
16. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition. Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model. Leonel C; Borin TF; de Carvalho Ferreira L; Moschetta MG; Bajgelman MC; Viloria-Petit AM; de Campos Zuccari DA J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):27-41. PubMed ID: 28078601 [TBL] [Abstract][Full Text] [Related]
18. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression. Leong H; Firestone GL; Bjeldanes LF Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
20. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]